| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0102 | ||||
| Gene Name | SLC16A11 | ||||
| Protein Name | Monocarboxylate transporter 11 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 7BP3_A Identity: 34.474% Minimized Score: -809.936 kcal/mol Detail: Structure Info |
||||
| Synonyms | MCT 11; MCT11; SLC16A11; Solute carrier family 16 member 11 | ||||
| DT Family | Major Facilitator Superfamily (MFS) | ||||
| Monocarboxylate Transporter (MCT) Family | |||||
| Tissue Specificity | Expressed in liver, salivary gland andthyroid. | ||||
| Function | This transporter is proton-linked monocarboxylate transporter, and it catalyzes the transport of pyruvate across the plasma membrane. | ||||
| Endogenous Substrate(s) | Monocarboxylates | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.